甲状腺乳头状癌合并鳞癌1例并文献复习  

Primary thyroid papillary carcinoma combined with squamous cell carcinoma:report of one case and review of literature

作　　者：刘玉婷 陈婕[1] 饶丹 吕毕[3] 宝荣[4] 方超[1] 谭兴容[1] Liu Yuting;Chen Jie;Rao Dan;Lü Bi;Bao Rong;Fang Chao;Tan Xingrong(Department of Endocrinology,The Ninth People’s Hospital of Chongqing;Department of General Surgery,Zengjia Hospital of Chongqing High-tech Zone;Department of Ultrasound,The Ninth People’s Hospital of Chongqing;Department of Pathology,The Ninth People’s Hospital of Chongqing)

机构地区：[1]重庆市第九人民医院内分泌科,重庆400799 [2]重庆市高新区曾家医院普外科,重庆401331 [3]重庆市第九人民医院超声科,重庆400799 [4]重庆市第九人民医院病理科,重庆400799

出　　处：《重庆医科大学学报》2022年第11期1289-1292,共4页Journal of Chongqing Medical University

摘　　要：甲状腺癌是近10年发病率增长最快的内分泌肿瘤之一,在所有恶性肿瘤中占比约3%[1]。其中,原发性甲状腺鳞状细胞癌(primary squamous cell carcinoma thyroid,PSCCT)临床极少见,占所有甲状腺癌的0.2%~1%[2]。但其恶性程度高、进展快、易转移、预后差,中位生存期仅6个月左右。

关 键 词：甲状腺乳头状癌 内分泌肿瘤 恶性程度 甲状腺癌 鳞癌 预后差 恶性肿瘤 中位生存期 

分 类 号：R736.1[医药卫生—肿瘤]